Monia Lunghi

4.8k total citations · 1 hit paper
60 papers, 1.8k citations indexed

About

Monia Lunghi is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Monia Lunghi has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 22 papers in Genetics and 18 papers in Molecular Biology. Recurrent topics in Monia Lunghi's work include Acute Myeloid Leukemia Research (28 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Monia Lunghi is often cited by papers focused on Acute Myeloid Leukemia Research (28 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Monia Lunghi collaborates with scholars based in Italy, United States and Germany. Monia Lunghi's co-authors include Gianluca Gaïdano, Pellegrino Musto, Davide Rossi, Daniela Capello, Valeria Santini, Robin Foà, Massimiliano Bonifacio, Mario Lazzarino, Alfonso Piciocchi and Sabina Chiaretti and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Monia Lunghi

57 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

2020 274 citations Robin Foà, Renato Bassan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monia Lunghi Italy	20	1.1k	636	492	458	390	60	1.8k
S N Wolff United States	16	1.1k 1.0×	292 0.5×	863 1.8×	423 0.9×	274 0.7×	22	2.1k
Sławomira Kyrcz‐Krzemień Poland	21	906 0.8×	279 0.4×	284 0.6×	135 0.3×	324 0.8×	115	1.4k
Anne Lennard United Kingdom	20	414 0.4×	562 0.9×	561 1.1×	218 0.5×	154 0.4×	51	1.6k
Lourdes Escoda Spain	20	977 0.9×	519 0.8×	567 1.2×	665 1.5×	206 0.5×	57	1.7k
Piero Galieni Italy	26	739 0.7×	564 0.9×	706 1.4×	487 1.1×	83 0.2×	89	1.7k
Isabelle Plantier France	12	843 0.8×	1.1k 1.8×	819 1.7×	480 1.0×	127 0.3×	22	2.2k
Bernard Lenormand France	20	355 0.3×	638 1.0×	512 1.0×	211 0.5×	153 0.4×	52	1.6k
Kaaren K. Reichard United States	22	515 0.5×	611 1.0×	413 0.8×	237 0.5×	100 0.3×	116	1.7k
Pascale Lepelley France	21	742 0.7×	299 0.5×	366 0.7×	376 0.8×	132 0.3×	51	1.2k
Gitte Kerndrup Denmark	27	1.5k 1.3×	433 0.7×	197 0.4×	638 1.4×	605 1.6×	71	2.1k

Countries citing papers authored by Monia Lunghi

Since Specialization

Citations

This map shows the geographic impact of Monia Lunghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monia Lunghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monia Lunghi more than expected).

Fields of papers citing papers by Monia Lunghi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monia Lunghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monia Lunghi. The network helps show where Monia Lunghi may publish in the future.

Co-authorship network of co-authors of Monia Lunghi

This figure shows the co-authorship network connecting the top 25 collaborators of Monia Lunghi. A scholar is included among the top collaborators of Monia Lunghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monia Lunghi. Monia Lunghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geißler, Klaus, Zdeněk Kořı́stek, Teresa Bernal, et al.. (2024). Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study. British Journal of Haematology. 205(5). 1734–1745. 8 indexed citations

Daver, Naval, Pau Montesinos, Jessica K. Altman, et al.. (2024). A phase 1b/2 study of pivekimab sunirine (PVEK, IMGN632) in combination with venetoclax/azacitidine for patients with newly diagnosed CD123-positive acute myeloid leukemia.. Journal of Clinical Oncology. 42(16_suppl). TPS6585–TPS6585. 1 indexed citations

Greco, Mariangela, et al.. (2024). A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab. International Medical Case Reports Journal. Volume 17. 861–867.

Foà, Robin, Renato Bassan, Loredana Elia, et al.. (2023). Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. Journal of Clinical Oncology. 42(8). 881–885. 56 indexed citations

Racca, Luisa, Silvia Polidoro, Sara Centonze, et al.. (2023). Role of Diacylglycerol Kinases in Acute Myeloid Leukemia. Biomedicines. 11(7). 1877–1877. 4 indexed citations

Chiaretti, Sabina, Renato Bassan, Antonio Vitale, et al.. (2019). S1617 A DASATINIB‐BLINATUMOMAB COMBINATION FOR THE FRONT‐LINE TREATMENT OF ADULT PH+ ALL PATIENTS. PRELIMINARY RESULTS OF THE GIMEMA LAL2116 D‐ALBA TRIAL; ON BEHALF OF GIMEMA ACUTE LEUKEMIA WORKING PARTY. HemaSphere. 3(S1). 746–746. 6 indexed citations

Meldi, Kristen, Tingting Qin, Francesca Buchi, et al.. (2015). Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia. Journal of Clinical Investigation. 125(5). 1857–1872. 129 indexed citations

Ruggeri, Marco, Alberto Tosetto, Francesca Palandri, et al.. (2014). Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment‐related risk factors. Journal of Thrombosis and Haemostasis. 12(8). 1266–1273. 86 indexed citations

Fianchi, Luana, Marianna Criscuolo, Monia Lunghi, et al.. (2012). Outcome of therapy-related myeloid neoplasms treated with azacitidine. Journal of Hematology & Oncology. 5(1). 44–44. 41 indexed citations

10.

Amadori, Sergio, Roberto Stasi, Alberto M. Martelli, et al.. (2011). Temsirolimus, an mTOR inhibitor, in combination with lower‐dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML‐1107). British Journal of Haematology. 156(2). 205–212. 59 indexed citations

11.

Maurillo, Luca, Adriano Venditti, Alessandra Spagnoli, et al.. (2011). Azacitidine for the treatment of patients with acute myeloid leukemia. Cancer. 118(4). 1014–1022. 82 indexed citations

12.

Musto, Pellegrino, Luca Maurillo, Alessandra Spagnoli, et al.. (2010). Azacitidine for the treatment of lower risk myelodysplastic syndromes. Cancer. 116(6). 1485–1494. 75 indexed citations

13.

Musto, Pellegrino, Luca Maurillo, Alessandra Spagnoli, et al.. (2009). P116 Azacitidine for the treatment of lower risk myelodysplastic syndromes: final results from an Italian named patient program. Leukemia Research. 33. S127–S127. 1 indexed citations

14.

Lunghi, Monia, et al.. (2009). Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature. Cancer Genetics and Cytogenetics. 196(1). 89–92. 1 indexed citations

15.

Capello, Daniela, Clara Deambrogi, Davide Rossi, et al.. (2008). Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia‐negative chronic myeloproliferative disorders. British Journal of Haematology. 141(4). 504–511. 48 indexed citations

16.

Rossi, Davide, Michaela Cerri, Daniela Capello, et al.. (2008). Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. British Journal of Haematology. 142(2). 202–215. 164 indexed citations

17.

Rossi, Davide, Silvia Franceschetti, Daniela Capello, et al.. (2007). Transient monoclonal expansion of CD8+/CD57+ T‐cell large granular lymphocytes after primary cytomegalovirus infection. American Journal of Hematology. 82(12). 1103–1105. 25 indexed citations

18.

Castagnola, Carlo, Monia Lunghi, Sabrina Caberlon, et al.. (2005). Long-Term Outcome of Ph-Negative Acute Lymphoblastic Leukaemia in Adults: A Single Centre Experience. Acta Haematologica. 113(4). 234–240. 4 indexed citations

19.

Passamonti, Francesco, Elisa Rumi, Luca Arcaini, et al.. (2005). Leukemic transformation of polycythemia vera. Cancer. 104(5). 1032–1036. 54 indexed citations

20.

Stabellini, G., et al.. (1994). EVALUATION OF PLASTICISER ACTIVITY ON CONNECTIVE TISSUE: HISTOLOGICAL, HISTOCHEMICAL AND BIOCHEMICAL VARIATIONS. Medical science research. 22(6). 395–397. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact